paralytic strabismus: An ocular deviation caused by a palsy to one or more of the extraocular muscles or nerves supplying them. [database_cross_reference: ORCID:0000-0003-0986-4123][database_cross_reference: ORCID:0000-0003-0986-4123]
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
3040 |
4. Check minimum number of eventsNone |
3040 |
5. Include endpoints |
3206 |
6. Filter based on genotype QC (FinnGen only) |
2845 |
Control definitions (FinnGen only)
- Control exclude
- H7_OCUMUSCLE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H49-H52
- Name in latin
- Strabismus paralyticus
Similar endpoints
↥List of similar endpoints to
Paralytic strabismus
based on the number of shared cases.
Similar with more cases:
- Strabismus
- Disorders of ocular muscles, binocular movement, accommodation and refraction
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 18942 | 9349 | 9495 |
| Only index persons | 16522 | 8232 | 8290 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.27 | 0.27 | 0.27 |
| Only index persons | 0.31 | 0.30 | 0.32 |
| Median age at first event (years) | |||
| Whole population | 61.07 | 61.75 | 60.34 |
| Only index persons | 60.55 | 61.10 | 60.01 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2845 | 1440 | 1405 |
| Unadjusted period prevalence (%) | 0.58 | 0.51 | 0.64 |
| Median age at first event (years) | 61.58 | 59.03 | 64.19 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2953
- Matched controls
- 29530
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H53.2
ICD-10 Finland
Diplopia
58.7
307.7
1153
319
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
11668.2
307.7
851
*
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
9028.6
307.7
705
*
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
16384.0
307.7
1320
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.0
304.1
629
1281
XCW99
NOMESCO Finland
Other investigative procedure of eye
5.1
289.4
744
1830
AA1AD
NOMESCO Finland
CT of head and brain
3.1
192.9
1378
6518
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
7.7
189.0
277
390
H50.2
ICD-10 Finland
Vertical strabismus
280.6
182.0
184
7
CE2W4
NOMESCO Finland
Eye movement mapping
77.1
180.9
97
13
XCK00
NOMESCO Finland
Perimetry
5.1
175.8
404
884
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.0
160.3
527
1520
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.1
149.3
836
3365
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
14.3
131.0
120
87
CEC00
NOMESCO Finland
Recession of extraocular muscle
1282.0
127.1
123
*
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
+∞
113.3
108
*
H50.0
ICD-10 Finland
Convergent concomitant strabismus
493.7
97.0
96
*
3785A
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Paralytic strabismus
+∞
95.3
91
*
G35
ICD-10 Finland
Multiple sclerosis
9.1
92.8
115
131
TAB00
NOMESCO Finland
Lumbar puncture
4.4
91.4
246
603
37304
ICD-8 Finland
Strabismus, paralyticus. Paresis nervorum III, IV, VI
+∞
91.1
87
*
G51.0
ICD-10 Finland
Bell palsy
5.3
81.3
170
338
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
12.5
79.8
79
65
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
14.5
78.5
71
50
H50.52
ICD-10 Finland
Exophoria
22.8
76.7
56
25
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
9.9
75.4
87
90
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
6.2
72.7
127
213
109
Kela drug reimbursment
Multiple sclerosis
9.9
71.8
83
86
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.8
71.5
421
1683
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
8.5
71.2
93
113
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
11.7
69.9
72
63
H49.9
ICD-10 Finland
Paralytic strabismus, unspecified
+∞
65.9
63
*
R51.80
ICD-10 Finland
Headache
2.3
62.0
544
2613
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.5
60.7
454
2030
H02.4
ICD-10 Finland
Ptosis of eyelid
4.2
59.0
161
397
G70.0
ICD-10 Finland
Myasthenia gravis
15.1
58.9
52
35
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
10.1
58.8
67
68
N07AA02
ATC
pyridostigmine; systemic
12.1
55.8
56
47
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
5.1
55.4
118
238
CEC60
NOMESCO Finland
Transposition of extraocular muscle with adjustable suture
+∞
55.4
53
*
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
3.5
53.3
194
585
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.9
53.2
274
1015
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
12.3
52.2
52
43
108
Kela drug reimbursment
Myasthenia gravis
16.4
49.6
42
26
B01AC04
ATC
clopidogrel; oral
2.0
48.9
631
3494
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
5.9
48.7
89
156
A10AB05
ATC
insulin aspart; parenteral
2.6
48.2
316
1321
H50.1
ICD-10 Finland
Divergent concomitant strabismus
243.9
47.1
48
*
A10AC01
ATC
insulin (human); parenteral
2.5
46.5
307
1287
CEW99
NOMESCO Finland
Other operation on extraocular muscle
465.0
46.4
46
*
H50.30
ICD-10 Finland
Intermittent esotropy
159.1
44.9
47
*
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
5.2
43.9
92
183
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
43.3
1314
9406
H53.1
ICD-10 Finland
Subjective visual disturbances
2.6
43.2
260
1041
A10AE04
ATC
insulin glargine; parenteral
2.3
42.4
374
1782
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.2
42.2
174
566
CEC30
NOMESCO Finland
Resection of extraocular muscle
+∞
41.8
40
*
CS494
NOMESCO Finland
Other visual field testing
3.8
41.3
128
346
XCK10
NOMESCO Finland
Photography of fundus of eye
2.3
41.0
355
1676
H49.8
ICD-10 Finland
Other paralytic strabismus
+∞
40.7
39
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
8.8
40.5
51
59
PA6AD
NOMESCO Finland
CT of neck arteries
3.1
40.5
172
570
H02.2
ICD-10 Finland
Lagophthalmos
11.9
40.3
41
35
N86
ICPC
Multiple sclerosis
9.9
40.1
46
47
H50.9
ICD-10 Finland
Strabismus, unspecified
87.3
38.9
43
5
L03AB07
ATC
interferon beta-1a; parenteral
10.4
38.7
43
42
H3603, E103,
ICD-10 Finland
7.2
38.6
57
80
A10AA02, ,
ATC
3.4
37.7
142
437
A10AB01
ATC
insulin (human); parenteral
3.4
37.3
138
420
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
3.3
36.4
144
457
H47.2
ICD-10 Finland
Optic atrophy
11.3
36.2
38
34
H50.8
ICD-10 Finland
Other specified strabismus
361.7
36.0
36
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.3
36.0
290
1326
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.1
35.9
152
502
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.9
35.8
107
282
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
8.0
35.4
48
61
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
12.7
34.9
34
27
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
33.7
1493
11507
CEC90
NOMESCO Finland
Total transposition of extraocular muscle or muscles
+∞
33.4
32
*
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
3.9
33.3
101
269
A10AA01, ,
ATC
3.7
32.8
104
286
R42
ICD-10 Finland
Dizziness and giddiness
1.7
32.7
737
4785
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
2.4
32.7
236
1027
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
6.8
32.7
51
76
H50.51
ICD-10 Finland
Esophoria
88.6
31.8
35
*
H50.31
ICD-10 Finland
Intermittent exotropia
114.6
31.7
34
*
PA7BD
NOMESCO Finland
CT angiography of neck and brain
4.4
31.7
81
190
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
5.6
31.6
60
109
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
5.3
31.5
63
120
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.4
30.8
213
909
H3601, E103,
ICD-10 Finland
6.8
30.6
48
72
A10AB04
ATC
insulin lispro; parenteral
3.3
30.5
119
374
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
5.6
30.4
58
106
H49.4
ICD-10 Finland
Progressive external ophthalmoplegia
+∞
30.3
29
*
L03AX13
ATC
glatiramer acetate; parenteral
11.1
30.2
32
29
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
5.8
30.2
55
96
H52.1
ICD-10 Finland
Myopia
4.9
30.0
66
137
S06.2
ICD-10 Finland
Diffuse brain injury
5.9
29.6
53
91
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
29.2
859
5947
T90.5
ICD-10 Finland
Sequelae of intracranial injury
4.9
28.8
63
130
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
5.6
28.0
53
96
F05
ICPC
Visual disturbance other
2.9
28.0
132
464
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
27.5
632
4101
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
8.3
27.4
36
44
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
3.4
27.4
102
312
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
6.7
27.2
43
65
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
5.6
27.1
51
92
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
26.4
762
5229
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
4.5
25.9
63
142
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.1
25.8
280
1435
H46
ICD-10 Finland
Optic neuritis
6.3
25.7
43
69
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
6.0
25.1
44
74
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.3
25.1
209
966
3503
FHL
Single muscle retroposition
+∞
25.0
24
*
H51.2
ICD-10 Finland
Internuclear ophthalmoplegia
+∞
25.0
24
*
SPAT1301
SPAT
No procedures
1.6
25.0
901
6498
H52.2
ICD-10 Finland
Astigmatism
6.2
24.6
42
69
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
27.8
24.5
33
12
H3601, E113,
ICD-10 Finland
3.9
24.4
73
193
S06.3
ICD-10 Finland
Focal brain injury
4.5
24.1
59
134
H50.4
ICD-10 Finland
Other and unspecified heterotropia
+∞
24.0
23
*
ZXA10
NOMESCO Finland
Bilateral
1.7
24.0
543
3495
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
6.8
23.8
37
55
G91.0
ICD-10 Finland
Communicating hydrocephalus
7.2
23.7
35
49
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
8.6
23.7
30
35
AAF00
NOMESCO Finland
Ventriculostomy
6.4
23.5
39
62
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
6.5
23.5
38
59
T89
ICPC
Diabetes insulin dependent
2.6
23.2
139
554
Z3229
NOMESCO Finland
Other healthcare associate professional
2.0
23.1
265
1386
H47.1
ICD-10 Finland
Papilloedema, unspecified
6.7
23.0
36
54
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.1
22.9
97
321
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
4.0
22.9
64
161
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
9.4
22.6
27
29
H36.01
ICD-10 Finland
Diabetic maculopathy
4.0
22.0
62
157
CKC12
NOMESCO Finland
Photocoagulation of retina
2.5
21.9
142
588
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
5.5
21.2
41
76
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
6.2
21.1
36
59
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
21.0
808
5867
CEC20
NOMESCO Finland
Recession and advancement of extraocular muscle
+∞
20.9
20
*
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
3.0
20.7
93
319
XA800
NOMESCO Finland
Neuropsychological investigation
2.4
20.5
138
581
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
3.5
20.5
70
203
A10AE05
ATC
insulin detemir; parenteral
2.2
20.5
177
831
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
20.3
754
5429
C10AA01
ATC
simvastatin; oral
1.4
20.2
1241
9867
ZXD05
NOMESCO Finland
Urgent procedure
1.5
19.8
834
6157
H57.1
ICD-10 Finland
Ocular pain
2.6
19.8
118
469
37300
ICD-8 Finland
Strabismus, Concomitans convergens
+∞
19.8
19
*
C08CA01
ATC
amlodipine; oral
1.4
19.8
1153
9068
L04AX01
ATC
azathioprine; systemic
2.5
19.7
128
530
H04AA01
ATC
glucagon; nasal, parenteral
3.4
19.7
72
218
H36.00
ICD-10 Finland
Diabetic background retinopathy
3.9
19.6
58
152
SPAT1262
SPAT
Handing over of treatment supplies
1.6
19.6
518
3451
SPAT1229
SPAT
Assessment of need for aid
1.9
19.4
247
1336
A10AD01
ATC
insulin (human); parenteral
3.4
19.3
70
211
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
2.4
19.2
140
611
N03AX16
ATC
[U] pregabalin
1.5
19.1
641
4508
C10AA05
ATC
atorvastatin; oral
1.4
19.1
1250
10025
Z3231
NOMESCO Finland
Registered nurse
1.5
18.9
761
5559
L04AX07
ATC
dimethyl fumarate; oral
14.9
18.9
31
21
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
18.8
525
3540
G46.3*I67.9
ICD-10 Finland
Brain stem stroke syndrome (I60-I67+)
7.4
18.7
27
37
H53.4
ICD-10 Finland
Visual field defects
3.1
18.6
77
252
H3603, E113,
ICD-10 Finland
4.4
18.3
46
107
G91.1
ICD-10 Finland
Obstructive hydrocephalus
6.9
18.2
28
41
E23.00
ICD-10 Finland
Panhypopituitarism
7.5
18.2
26
35
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
5.2
18.2
37
72
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
3.7
17.8
57
158
CEC80
NOMESCO Finland
Partial transposition of extraocular muscle
+∞
17.7
17
*
H02AB09
ATC
hydrocortisone; systemic
3.0
17.7
79
270
F95
ICPC
Strabismus
36.9
17.6
22
6
XCD10
NOMESCO Finland
Electrophysiological examination of eye
2.9
17.5
84
299
E10
ICD-10 Finland
Type 1 diabetes mellitus
3.4
17.4
63
190
H53.9
ICD-10 Finland
Visual disturbance, unspecified
2.4
17.1
118
503
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
7.2
17.0
25
35
164
Kela drug reimbursment
Fingolimod
17.5
16.9
26
15
353
Kela drug reimbursment
Cladribine and fingolimod
19.4
16.9
25
13
CKC15
NOMESCO Finland
Panretinal photocoagulation
4.4
16.9
42
97
SPAT1263
SPAT
Sampling
1.4
16.8
1113
8881
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
3.3
16.8
62
189
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
2.5
16.7
110
459
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
16.7
393
2538
H50.6
ICD-10 Finland
Mechanical strabismus
+∞
16.7
16
*
N02BE01
ATC
paracetamol; systemic, rectal
1.6
16.7
2554
23622
XCW11
NOMESCO Finland
Assessment of strabismus
90.6
16.6
18
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
16.5
210
1136
H52.3
ICD-10 Finland
Anisometropia and aniseikonia
13.4
16.4
28
21
N18
ICPC
Paralysis/weakness
2.9
16.4
77
271
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
6.1
16.4
28
46
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
16.4
823
6248
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.8
16.3
260
1509
G71.3
ICD-10 Finland
Mitochondrial myopathy, not elsewhere classified
40.3
16.3
20
5
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
16.3
952
7424
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
16.3
623
4487
T90
ICPC
Diabetes non-insulin dependent
1.5
16.2
716
5301
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
5.8
16.2
29
50
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
6.0
16.0
28
47
ZXC95
NOMESCO Finland
Use of surgical navigator
3.8
16.0
49
132
WX140
NOMESCO Finland
Parabulbar anesthesy
2.1
16.0
154
755
A02BC02
ATC
pantoprazole; systemic
1.4
15.9
1921
16873
J01DB01
ATC
cefalexin; oral
1.5
15.9
2297
20831
SPAT1153
SPAT
Removal of sutures
1.4
15.7
869
6704
H50.59
ICD-10 Finland
Heterophor UNS
+∞
15.6
15
*
H51.8
ICD-10 Finland
Other specified disorders of binocular movement
+∞
15.6
15
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
15.6
466
3182
A10AE06
ATC
insulin degludec; parenteral
2.4
15.5
108
463
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.1
15.2
152
756
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.1
15.1
62
202
SPAT1312
SPAT
General health counselling
1.4
15.1
808
6189
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
14.0
15.0
25
18
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
3.7
15.0
47
129
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.9
15.0
70
246
A28
ICPC
Limited function/disability NOS
1.5
14.9
561
4020
G52.8
ICD-10 Finland
Disorders of other specified cranial nerves
57.0
14.8
17
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
14.8
1789
15622
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.6
14.8
327
2077
N03AX12
ATC
[U] gabapentin; oral
1.6
14.7
433
2944
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
5.3
14.7
29
55
37303
ICD-8 Finland
Strabismus, Heterophoria (exophoria, esophroria, hypophoria)
+∞
14.6
14
*
H49.3
ICD-10 Finland
Total (external) ophthalmoplegia
+∞
14.6
14
*
XCW20
NOMESCO Finland
Eye Movement Research, HESS
80.5
14.6
16
*
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.3
14.5
112
502
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
14.3
731
5543
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
14.3
446
3069
H3600, E103,
ICD-10 Finland
4.1
14.3
39
97
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
3.8
14.2
43
115
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
3.3
14.2
53
163
H52.0
ICD-10 Finland
Hypermetropia
4.3
14.1
36
85
N28
ICPC
Limited function/disability (N)
2.9
14.1
67
238
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
3.3
13.9
52
160
H02AB06
ATC
prednisolone; systemic
1.4
13.9
1302
10889
8000/0-C70.0
ICD-O-3
Neoplasm, benign of cerebral meninges
6.0
13.9
24
40
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.3
13.8
106
474
L04AA27
ATC
[U] fingolimod
17.6
13.8
21
12
205
Kela drug reimbursment
Chronic hypertension
1.4
13.8
785
6060
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
13.8
1015
8176
S02.10
ICD-10 Finland
Fracture of base of skull, closed
6.3
13.7
23
37
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
2.6
13.7
81
322
I60.7
ICD-10 Finland
Subarachnoid haemorrhage from intracranial artery, unspecified
6.5
13.6
22
34
A10BA02
ATC
metformin; oral
1.4
13.5
812
6324
SPAT1216
SPAT
Assessment of functional ability
1.5
13.5
446
3106
H16.0
ICD-10 Finland
Corneal ulcer
2.1
13.5
135
672
N03AX14
ATC
levetiracetam; systemic
2.4
13.5
88
367
N29
ICPC
Neurological sympt/complt other
2.8
13.5
67
244
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
16.3
13.4
21
13
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.0
13.3
146
751
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
13.2
677
5128
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
13.2
951
7622
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
13.1
210
1220
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.5
13.1
522
3772
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.4
13.1
922
7359
H53.0
ICD-10 Finland
Amblyopia ex anopsia
4.8
13.1
29
61
H26.4
ICD-10 Finland
After-cataract
1.6
13.0
299
1914
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
1.9
13.0
158
843
ZXA05
NOMESCO Finland
Left side
1.4
13.0
662
5008
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
12.9
1098
9016
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
2.6
12.9
71
273
UJF32
NOMESCO Finland
Coloscopy
1.4
12.8
714
5480
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.7
12.8
238
1444
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
5.8
12.7
23
40
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.5
12.7
372
2521
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
12.7
441
3100
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
4.1
12.6
34
84
3507
FHL
Retroposition and resection
+∞
12.5
12
*
H51.9
ICD-10 Finland
Disorder of binocular movement, unspecified
+∞
12.5
12
*
CKC10
NOMESCO Finland
Local photocoagulation of retina
2.7
12.5
64
237
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
12.5
606
4541
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
12.4
349
2343
S18
ICPC
Laceration/cut
1.3
12.4
1300
10987
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.8
12.3
190
1092
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
12.3
878
7008
H3600, E113,
ICD-10 Finland
3.3
12.3
46
142
H43.1
ICD-10 Finland
Vitreous haemorrhage
2.4
12.3
80
333
SPAT1260
SPAT
Consultation of another employee
1.5
12.2
458
3266
N03AF02
ATC
oxcarbazepine; oral
2.3
12.2
93
415
177
Kela drug reimbursment
Insulin glargine 300 U / ml
2.7
12.2
63
234
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
9.7
12.2
24
25
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
12.2
363
2469
L28
ICPC
Limited function/disability (L)
1.4
12.2
554
4100
A10AD05
ATC
insulin aspart; parenteral
2.6
12.1
67
258
K90
ICPC
Stroke/cerebrovascular accident
2.2
12.1
98
449
A10BB01
ATC
glibenclamide; oral
2.0
12.1
125
630
H04.10
ICD-10 Finland
Dry eye syndrome
1.6
12.1
300
1958
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.7
12.0
228
1390
SPAT1310
SPAT
Counselling related to known health issue
1.4
12.0
815
6452
PAW37
NOMESCO Finland
Biopsy of temporal artery
4.4
11.9
29
66
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
3.7
11.8
36
97
A06AD11
ATC
lactulose; oral
1.5
11.7
425
3013
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
16.5
11.7
18
11
L03AB08
ATC
interferon beta-1b; parenteral
12.6
11.6
20
16
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
2.4
11.6
78
330
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
2.6
11.6
63
241
XCW10
NOMESCO Finland
Assessment of vision
2.9
11.5
53
185
37302
ICD-8 Finland
Strabismus, Concomitans sursum sive deorsum vergens
+∞
11.5
11
*
3783A
ICD-9 Finland
Strabismus and other disorders of binocular eye movements, Other and unspecified heterotropia
+∞
11.5
11
*
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.1
11.4
103
493
PA2AD
NOMESCO Finland
CT angiography of brain
3.7
11.4
35
95
S06.0
ICD-10 Finland
Concussion
1.6
11.3
286
1874
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
2.8
11.3
54
193
R53
ICD-10 Finland
Malaise and fatigue
1.4
11.3
668
5167
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
11.2
911
7394
R4150
NOMESCO Finland
Neuropsychological rehabilitation
4.1
11.1
30
74
L04AA31
ATC
[U] teriflunomide
12.7
11.1
19
15
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.5
11.1
325
2202
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
4.4
11.0
27
62
G44.2
ICD-10 Finland
Tension-type headache
1.5
11.0
326
2215
N06AB10
ATC
escitalopram; oral
1.4
10.8
467
3417
101
Kela drug reimbursment
Anterior pituitary hypofunction
4.3
10.8
27
63
C09AA05
ATC
ramipril; oral
1.4
10.7
704
5526
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
3.6
10.6
34
95
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.5
10.6
350
2430
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
10.6
197
1195
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
3.2
10.5
40
125
H57.0
ICD-10 Finland
Anomalies of pupillary function
4.8
10.5
23
48
WZC00
NOMESCO Finland
Treatment plan or consultation
1.3
10.4
955
7868
3505
FHL
Single muscle resection
+∞
10.4
10
*
H52.5
ICD-10 Finland
Disorders of accommodation
+∞
10.4
10
*
37301
ICD-8 Finland
Strabismus, Concomitans divergens
+∞
10.4
10
*
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.8
10.4
144
802
G52.9
ICD-10 Finland
Cranial nerve disorder, unspecified
32.6
10.3
13
*
N18.8
ICD-10 Finland
Other chronic renal failure
2.3
10.3
75
329
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
10.3
651
5076
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
3.9
10.3
29
74
ZX120
NOMESCO Finland
Intravenous
1.6
10.3
247
1599
CBH25
NOMESCO Finland
Tarsorrhaphy
18.8
10.3
15
8
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
18.8
10.3
15
8
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
4.6
10.2
24
53
N01
ICPC
Headache
1.6
10.2
250
1626
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
3.1
10.2
41
133
WX110
NOMESCO Finland
Infiltration anesthesia
1.3
10.2
1885
17010
C03CA01
ATC
furosemide; systemic
1.3
10.1
888
7264
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
5.3
10.1
20
38
H3602, E113,
ICD-10 Finland
9.1
10.0
20
22
XX3DW
NOMESCO Finland
Time consuming IT work
1.5
10.0
292
1976
OAB50, ,
SPAT
1.6
10.0
223
1418
SPAT1325
SPAT
Vaccination
1.3
10.0
874
7148
C09AA02
ATC
enalapril; systemic
1.4
9.9
533
4050
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.4
9.9
396
2857
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.6
9.8
246
1607
AAL00
NOMESCO Finland
Endovascular occlusion of intracranial aneurysm
12.2
9.8
17
14
S02.11
ICD-10 Finland
Fracture of base of skull, open
8.1
9.8
21
26
CBJ10
NOMESCO Finland
Fascia plate sling or synthetic material for ptosis correction
26.1
9.8
13
5
C09CA01
ATC
losartan; oral
1.3
9.7
700
5561
UKC02
NOMESCO Finland
Cystoscopy
1.4
9.7
446
3297
N03AF01
ATC
carbamazepine; oral, rectal
1.8
9.7
134
746
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
7.4
9.7
22
30
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.9
9.6
128
704
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
3.5
9.6
32
92
V03AE01
ATC
polystyrene sulfonate; oral
2.9
9.6
44
154
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
2.6
9.6
54
211
NHQ40
NOMESCO Finland
Amputation of toe
2.7
9.5
51
194
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
9.1
9.5
19
21
WX882
NOMESCO Finland
High dependency care
2.2
9.5
82
387
R51
ICD-10 Finland
Headache
1.9
9.5
126
693
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
9.5
763
6158
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
3.5
9.5
32
93
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
3.5
9.5
32
93
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
3.2
9.4
36
113
H51.1
ICD-10 Finland
Convergence insufficiency and excess
100.4
9.4
10
*
S04.1
ICD-10 Finland
Injury of oculomotor nerve
100.4
9.4
10
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
9.4
1094
9273
N06AX11
ATC
mirtazapine; oral
1.3
9.4
859
7055
D33.12
ICD-10 Finland
Cerebellum
+∞
9.4
9
*
PA6AG
NOMESCO Finland
Limited MRI examination of neck vasculature with high intensity magnet
4.2
9.4
24
57
A10BH01
ATC
sitagliptin; oral
1.5
9.4
263
1764
K91
ICPC
Cerebrovascular disease
2.7
9.3
47
173
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.5
9.3
281
1915
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
4.7
9.3
21
45
ZXC86
NOMESCO Finland
Use of endoscopic device
4.7
9.3
21
45
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.9
9.2
111
591
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.3
9.2
69
307
C10AX09
ATC
ezetimibe; oral
1.4
9.2
456
3413
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
9.2
306
2127
G04BD09
ATC
trospium; oral
2.3
9.2
69
308
M79.6
ICD-10 Finland
Pain in limb
1.3
9.2
1121
9554
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
9.1
391
2853
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
9.1
774
6288
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
9.1
701
5617
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
4.4
9.1
22
50
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
9.1
897
7438
N02AX02
ATC
tramadol; systemic, rectal
1.3
9.1
1132
9668
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
4.6
9.1
21
46
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
3.8
9.0
27
72
D33.30
ICD-10 Finland
Acoustic neuroma
4.0
9.0
25
63
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.6
9.0
234
1543
TK800
NOMESCO Finland
Hemodialysis
2.4
8.9
61
261
I63.8
ICD-10 Finland
Other cerebral infarction
3.2
8.9
35
112
H3603, E107,
ICD-10 Finland
24.1
8.9
12
5
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
2.5
8.9
56
231
N07XX09
ATC
[U] dimethyl fumarate
12.6
8.9
15
12
B01AC07
ATC
dipyridamole; systemic
1.8
8.8
126
711
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.4
8.8
498
3811
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
8.7
960
8062
H53.8
ICD-10 Finland
Other visual disturbances
2.8
8.7
43
157
XCH00
NOMESCO Finland
Eye pressure measurement
1.8
8.7
129
735
GEC24
NOMESCO Finland
Thoracoscopic thymectomy
14.1
8.7
14
10
D33.37
ICD-10 Finland
Another benign tumor of the cranial nerves
50.1
8.7
10
*
JN3AD
NOMESCO Finland
Abdominal CT examination
1.4
8.6
344
2476
R11
ICD-10 Finland
Nausea and vomiting
1.6
8.6
220
1445
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.7
8.6
173
1072
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.3
8.6
65
291
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.7
8.6
138
805
SPAT1254
SPAT
Administration of medicine
1.4
8.6
384
2823
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
8.2
8.6
18
22
G04CA02
ATC
tamsulosin; oral
1.3
8.5
672
5395
N02BF01
ATC
gabapentin; oral
1.5
8.5
263
1799
A10BB12
ATC
glimepiride; oral
1.6
8.5
192
1224
H25.0
ICD-10 Finland
Senile incipient cataract
1.6
8.5
176
1099
H25.8
ICD-10 Finland
Other senile cataract
1.5
8.4
314
2232
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
2.4
8.4
53
219
J01CA04
ATC
amoxicillin; systemic
1.3
8.4
2174
20183
D33.11
ICD-10 Finland
Brain stem
+∞
8.3
8
*
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
10.8
8.3
15
14
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.5
8.2
255
1747
S02.30
ICD-10 Finland
Fracture of orbital floor, closed
3.3
8.2
30
92
N05CF01
ATC
zopiclone; oral
1.3
8.2
826
6850
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
8.2
406
3037
L01AX03
ATC
temozolomide; systemic
3.7
8.2
25
68
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
4.4
8.1
20
46
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
3.1
8.1
33
108
C07AB07
ATC
bisoprolol; oral
1.3
8.1
1350
11877
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.7
8.1
153
933
CBJ40
NOMESCO Finland
Resection of levator muscle of eyelid
3.4
8.1
28
83
A10AA03, ,
ATC
3.2
8.1
30
93
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
8.1
1022
8713
I60.3
ICD-10 Finland
Subarachnoid haemorrhage from posterior communicating artery
10.0
8.0
15
15
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.3
8.0
654
5272
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.4
8.0
343
2503
ZXA00
NOMESCO Finland
Right side
1.3
8.0
675
5469
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.4
7.9
372
2756
N03AX18
ATC
lacosamide; systemic
4.0
7.9
22
56
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
7.9
175
1113
SPAT1053
SPAT
Memory test
1.4
7.9
384
2864
-, ,
ICD-10 Finland
2.2
7.9
62
283
L01
ICPC
Neck symptom/complaint
1.4
7.8
388
2900
WX872
NOMESCO Finland
Intensive care
1.7
7.8
136
811
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.6
7.8
181
1162
G47.3
ICD-10 Finland
Sleep apnoea
1.3
7.8
570
4525
C01DA14
ATC
isosorbide mononitrate; oral
1.4
7.8
440
3361
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
9.4
7.8
15
16
C08CA02
ATC
felodipine; oral
1.5
7.8
254
1760
S22
ICPC
Nail symptom/complaint
1.6
7.8
174
1109
Z2446
NOMESCO Finland
Social worker
1.6
7.7
157
976
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
7.7
466
3595
D33.10
ICD-10 Finland
Benign pilosytic astrocytoma of brain stem
45.1
7.7
9
*
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.3
7.7
683
5563
G91.8
ICD-10 Finland
Other hydrocephalus
15.0
7.7
12
8
Z2445
NOMESCO Finland
Psychologist
2.0
7.7
85
441
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.8
7.7
36
128
NGJ70
NOMESCO Finland
External fixation of fracture of knee or lower leg, other or unspecified
4.3
7.7
19
44
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
7.6
312
2255
A02BC03
ATC
lansoprazole; oral
1.3
7.6
728
5985
R13
ICD-10 Finland
Dysphagia
1.6
7.6
189
1235
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.6
7.5
151
936
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
7.5
429
3280
S97
ICPC
Chronic ulcer skin
1.6
7.5
177
1142
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.8
7.5
118
685
XKD00
NOMESCO Finland
Uroflowmetry
1.4
7.5
428
3273
L04AA06
ATC
mycophenolic acid; systemic
2.4
7.4
50
213
R1250
NOMESCO Finland
Evaluation of functional capability
2.1
7.4
69
336
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.7
7.4
141
862
78110
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Diplopia
80.3
7.4
8
*
H40.0
ICD-10 Finland
Glaucoma suspect
1.5
7.4
197
1307
J01FF01
ATC
clindamycin; systemic
1.3
7.4
668
5452
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
7.4
271
1922
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
4.0
7.3
20
50
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
2.1
7.3
67
325
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.8
7.3
99
550
H50
ICD-10 Finland
Other strabismus
+∞
7.3
7
*
CA1BM
NOMESCO Finland
Eye and orbita MRI examination with 3 Tesla magnet
+∞
7.3
7
*
CEC50
NOMESCO Finland
Advancement of extraocular muscle
+∞
7.3
7
*
CEC85
NOMESCO Finland
Combined correction of cyclodeviation
+∞
7.3
7
*
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.3
7.3
685
5617
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
3.2
7.3
28
89
ZZC00
NOMESCO Finland
Graft of fascia
15.8
7.2
11
7
XF400
NOMESCO Finland
ECG with 12 standard connections
1.4
7.2
406
3097
M86.6
ICD-10 Finland
Other chronic osteomyelitis
5.8
7.2
19
33
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
3.7
7.2
22
60
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
2.8
7.2
34
122
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
3.9
7.2
20
51
ZXE20
NOMESCO Finland
More than three and less than five hours
1.4
7.1
336
2490
PA2YT
NOMESCO Finland
Cerebral artery PTA with stent
6.6
7.1
17
26
TCG00
NOMESCO Finland
Protection of cornea and sclera with soft lens
6.6
7.1
17
26
N06AA09
ATC
amitriptyline; systemic
1.5
7.1
227
1567
H50.50
ICD-10 Finland
Alternating hyperphoria
12.0
7.1
12
10
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.8
7.1
100
563
G44.8
ICD-10 Finland
Other specified headache syndromes
2.6
7.0
39
152
WF099
NOMESCO Finland
Other radiotherapy
3.6
7.0
22
61
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.6
7.0
179
1177
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.6
7.0
169
1097
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
7.0
7.0
16
23
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.5
7.0
228
1580
G50.1
ICD-10 Finland
Atypical facial pain
2.4
6.9
46
195
SPAT1054
SPAT
Examination of peripheral nervous system
2.4
6.9
46
195
R4110, ,
SPAT
1.4
6.9
335
2494
M14.6*E10.6
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic neuropathic
7.5
6.9
15
20
N06AX16
ATC
venlafaxine; oral
1.4
6.9
304
2229
N17
ICPC
Vertigo/dizziness
1.4
6.9
332
2471
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.3
6.9
709
5878
U02
ICPC
Urinary frequency/urgency
1.4
6.9
356
2681
W19
ICD-10 Finland
Unspecified fall
1.4
6.8
252
1787
A10AB06
ATC
insulin glulisine; parenteral
2.9
6.8
30
103
N30.0
ICD-10 Finland
Acute cystitis
1.3
6.8
410
3157
RS221, ,
NOMESCO Finland
2.5
6.8
40
160
H05.2
ICD-10 Finland
Exophthalmic conditions
8.3
6.8
14
17
J01DA01
ATC
[U] cefalexin
1.2
6.8
1580
14300
N02AA05
ATC
oxycodone; systemic
1.3
6.8
504
4002
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.1
6.8
61
294
Z50.1
ICD-10 Finland
Other physical therapy
1.7
6.8
132
814
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
4.3
6.7
17
40
K89
ICPC
Transient cerebral ischaemia
2.7
6.7
35
132
D07AC01
ATC
betamethasone; topical
1.2
6.7
915
7829
H65.2
ICD-10 Finland
Chronic serous otitis media
2.6
6.7
37
144
AN4
HP
Balloon angioplasty and drug eluding stent
1.8
6.7
91
507
C71.60
ICD-10 Finland
Malignant tumor of cerebellum without histology
22.6
6.7
9
*
D32
ICD-10 Finland
Benign neoplasm of meninges
22.6
6.7
9
*
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.4
6.6
281
2045
G63.2
ICD-10 Finland
Diabetic polyneuropathy
4.0
6.6
18
45
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.7
6.6
117
703
183
Kela drug reimbursment
Lamotrigin and topiramate
3.6
6.6
21
59
F29
ICPC
Eye symptom/complaint other
1.4
6.6
249
1775
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
2.7
6.6
34
128
R60.0
ICD-10 Finland
Localized oedema
1.4
6.6
326
2437
A46
ICD-10 Finland
Erysipelas
1.3
6.6
383
2937
X58
ICD-10 Finland
Exposure to other specified factors
1.4
6.6
345
2603
PA2MT
NOMESCO Finland
Endovascular closure of very extensive brain aneurysm
8.7
6.5
13
15
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.7
6.5
112
667
WX002
NOMESCO Finland
Sedation and analgesia
1.3
6.5
477
3778
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
2.0
6.5
64
319
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
2.8
6.5
32
117
AA3AD
NOMESCO Finland
CT of face
3.0
6.5
28
95
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.4
6.5
262
1888
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.7
6.5
102
592
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
6.5
620
5083
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
6.5
730
6104
K02.1
ICD-10 Finland
Caries of dentine
1.2
6.5
1442
12964
G04BD12
ATC
mirabegron; oral
1.4
6.5
313
2328
A10BJ06
ATC
semaglutide; parenteral
1.6
6.5
128
792
H02AB02
ATC
dexamethasone; systemic
1.4
6.4
285
2090
N04BB01
ATC
amantadine; oral
2.5
6.4
38
153
C10AC01
ATC
colestyramine; oral
2.0
6.4
64
321
AA2DG
NOMESCO Finland
Very extensive magnetic examination of the head and orbit
70.0
6.4
7
*
L04AA40
ATC
cladribine; oral
70.0
6.4
7
*
I77.0
ICD-10 Finland
Arteriovenous fistula, acquired
7.4
6.4
14
19
CBJ99
NOMESCO Finland
Other operation for ptosis
14.3
6.4
10
7
TKC22
NOMESCO Finland
Catheterisation instruction
2.0
6.4
66
336
N03AB02
ATC
phenytoin; systemic
2.7
6.3
33
125
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
5.2
6.3
18
35
R39.1
ICD-10 Finland
Other difficulties with micturition
1.9
6.3
79
429
XX4AW, ,
NOMESCO Finland
11.0
6.3
11
10
H33.2
ICD-10 Finland
Serous retinal detachment
5.5
6.3
17
31
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
9.3
6.3
12
13
H3602, E103,
ICD-10 Finland
9.3
6.3
12
13
G70.9
ICD-10 Finland
Myoneural disorder, unspecified
18.0
6.3
9
5
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.7
6.2
104
615
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.8
6.2
92
526
L04AD02
ATC
tacrolimus; systemic
2.9
6.2
28
98
M03BX01
ATC
baclofen; systemic
2.2
6.2
49
225
H53.3
ICD-10 Finland
Other disorders of binocular vision
5.0
6.2
18
36
Z49.2
ICD-10 Finland
Other dialysis
3.1
6.2
24
77
K08.3
ICD-10 Finland
Retained dental root
1.5
6.2
199
1377
OAB43, ,
SPAT
0.7
6.2
349
4503
TKC20
NOMESCO Finland
Catheterisation of bladder
1.5
6.1
176
1188
R52.9
ICD-10 Finland
Pain, unspecified
1.4
6.1
242
1739
PA2CG
NOMESCO Finland
Extensive MRI examination of vessels in the head with high intensity magnet
5.7
6.1
16
28
H03AA01
ATC
levothyroxine sodium; systemic
1.3
6.1
537
4357
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
2.0
6.1
59
293
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
2.2
6.1
50
233
N03AG01
ATC
valproic acid; systemic, rectal
1.6
6.1
134
852
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
1.8
6.1
86
485
N06AX21
ATC
duloxetine; oral
1.4
6.1
266
1947
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
12.5
6.1
10
8
9531/0-C70.0
ICD-O-3
Meningothelial meningioma of cerebral meninges
12.5
6.1
10
8
E66.00
ICD-10 Finland
Metabolic syndrome
1.6
6.1
132
837
C09BA02
ATC
enalapril and diuretics; systemic
1.5
6.0
202
1407
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
198
139
15.20
220.96
1.1
1.1
3.17
7.00
nmol/l
0.91
38
32
302
649
5.07
133.11
1.5
1.4
611.77
579.06
mg/l
0.23
294
617
267
582
4.94
115.36
1.4
1.3
3.82
3.76
mmol/l
0.36
259
550
263
580
4.88
111.99
1.6
1.5
1192.81
789.68
e6/l
0.28
215
459
260
572
4.89
111.02
1.6
1.5
68.87
37.06
e6/l
0.31
200
422
1429
8516
2.31
106.16
2.5
2.2
154.48
217.00
u/l
2.61
1373
8066
122
126
10.06
105.98
1.1
1.1
1.27
1.17
u/l
0.34
60
61
132
166
8.28
98.43
1.2
1.2
59.62
42.14
mg/l
0.68
102
138
127
159
8.30
95.03
1.1
1.1
402.93
288.38
mg/l
0.66
105
136
146
226
6.74
90.52
1.1
1.1
—
—
—
0
0
121
154
8.15
89.29
1.1
1.1
—
—
—
0
0
105
126
8.60
81.26
1.4
1.2
0.59
0.53
ratio
0.71
42
75
809
4338
2.19
71.72
1.9
2.1
28.79
29.76
s
5.40
778
4222
387
1567
2.69
63.74
1.3
1.3
66.88
55.44
au/ml
0.46
18
109
410
1712
2.62
63.47
2.5
2.4
18.67
21.45
au/ml
0.32
28
157
124
255
5.03
56.92
1.9
1.5
—
—
—
0
0
2020
15797
1.88
53.49
6.9
5.3
7.05
6.78
mmol/l
5.78
1942
15057
102
192
5.47
51.71
1.5
1.2
2.06
2.12
mmol/l
0.18
94
179
1441
10416
1.75
47.14
4.8
4.0
43.39
105.62
ng/l
0.84
1119
7681
1701
12924
1.75
46.23
14.2
17.0
1.23
1.30
inr
6.16
1438
10816
61
98
6.33
36.41
1.1
1.1
725.55
266.08
ng/l
0.46
15
24
393
2022
2.09
36.36
3.0
3.0
9.92
10.71
g/l
3.23
357
1865
1593
12358
1.63
35.91
9.1
6.8
1.21
1.21
mmol/l
0.90
1483
11429
1726
13736
1.62
34.37
9.8
7.5
1.21
1.21
mmol/l
0.08
1490
11894
44
56
7.96
32.38
1.1
1.3
—
—
—
0
0
1071
7681
1.62
32.22
5.2
4.2
0.02
0.00
estimate
0.36
341
2658
1562
12255
1.58
32.04
5.9
5.2
35.07
35.26
g/l
0.64
1486
11504
2045
17114
1.63
31.83
6.2
4.9
459.62
1666.37
e6/l
1.79
39
251
244
1091
2.35
31.79
1.9
1.9
37.65
39.57
u/l
0.62
218
960
60
113
5.40
30.42
1.8
1.8
—
—
—
0
0
65
139
4.76
28.52
1.2
1.1
—
—
—
0
0
49
81
6.13
28.46
1.2
1.1
—
—
—
0
0
550
3416
1.75
28.09
8.5
7.8
12.28
12.15
kpa
0.24
528
3277
550
3416
1.75
28.09
8.6
7.8
5.12
5.11
kpa
0.08
527
3275
546
3387
1.75
28.00
8.6
7.8
1.06
0.94
mmol/l
0.27
454
2781
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
61
127
4.88
27.63
1.1
1.1
—
—
—
0
0
2192
18946
1.61
27.06
5.2
4.4
13.22
12.80
mm/h
0.63
2058
17699
1650
13400
1.52
26.88
8.0
6.3
0.04
0.04
e9/l
0.08
1448
11411
1643
13370
1.52
26.22
8.0
6.3
0.61
0.60
e9/l
0.75
1438
11386
1682
13792
1.51
25.61
8.2
6.6
0.20
0.19
e9/l
0.96
1493
11941
492
3042
1.74
25.30
8.8
8.1
95.94
95.54
%
1.06
478
2925
1666
13657
1.50
25.23
8.0
6.4
1.85
1.90
e9/l
0.53
1487
11926
1681
13809
1.50
25.17
5.0
4.1
3.53
4.23
estimate
0.07
376
2976
55
114
4.90
25.06
1.1
1.2
—
—
—
0
0
1690
13911
1.50
24.96
5.1
4.1
0.02
0.12
estimate
0.47
344
2766
1711
14144
1.50
24.57
7.3
6.7
11.11
11.92
umol/l
2.28
1641
13507
1654
13647
1.48
23.48
5.0
4.0
0.00
0.00
estimate
0.41
365
2894
867
6273
1.54
23.40
3.4
2.8
4.46
5.26
e6/l
1.73
796
5731
410
2461
1.77
23.24
3.0
2.2
357.60
383.02
nmol/l
1.90
381
2266
576
3797
1.64
23.09
7.6
6.2
1.06
1.04
mmol/l
0.89
542
3536
1289
10251
1.46
21.33
5.0
4.0
0.01
0.04
estimate
1.17
304
2395
39
69
5.71
21.17
1.1
1.1
—
—
—
0
0
446
2814
1.69
21.01
9.5
8.7
120.61
121.01
g/l
0.15
438
2742
1773
15003
1.45
20.91
11.1
9.7
4.40
4.20
e9/l
2.08
1568
12976
310
1766
1.84
20.80
9.7
6.7
24.94
24.43
mmol/l
1.61
297
1683
27
33
8.25
20.51
1.1
1.2
—
—
—
0
0
38
68
5.65
20.38
1.0
1.1
—
—
—
0
0
2244
19945
1.52
20.21
10.2
8.5
83.63
80.17
u/l
1.67
2130
18960
37
67
5.58
19.61
1.0
1.1
—
—
—
0
0
40
79
5.12
19.30
1.1
1.2
44.00
15.30
%
—
5
10
50
119
4.26
19.28
1.7
1.2
31.20
70.76
%
—
5
17
686
4900
1.52
19.00
2.0
1.9
—
—
—
0
0
2646
24553
1.75
18.80
23.5
17.6
23.29
25.55
mg/l
3.48
2289
20505
2495
22826
1.60
18.51
6.2
5.3
1.95
1.95
mu/l
0.06
2316
21015
2161
19189
1.47
18.37
5.0
4.3
15.05
14.86
pmol/l
2.73
1980
17537
2698
25229
1.80
17.94
28.5
21.0
139.55
139.64
mmol/l
1.13
2659
24747
2699
25271
1.79
17.45
28.7
21.2
3.99
3.99
mmol/l
0.49
2653
24747
24
31
7.80
17.42
1.1
1.2
—
—
—
0
0
899
6875
1.44
17.38
4.8
4.3
90.34
87.28
%
3.33
877
6731
37
75
4.98
17.35
1.1
1.1
—
—
—
0
0
391
2499
1.65
17.33
2.5
2.7
66.54
66.25
g/l
0.31
359
2310
1475
12336
1.39
16.90
3.3
2.9
—
—
estimate
—
0
0
534
3697
1.54
16.86
1.9
1.8
—
—
—
0
0
1124
9000
1.40
16.59
4.3
3.5
59.10
78.90
e6/l
0.70
920
6934
1096
8756
1.40
16.32
3.5
3.3
1400.55
1536.71
ng/l
0.49
956
7591
795
6022
1.44
15.92
5.5
4.2
1.02
1.27
kg/l
0.50
525
4029
457
3097
1.56
15.80
9.3
7.4
—
—
—
0
0
53
153
3.51
15.66
1.8
1.9
—
—
—
0
0
411
2742
1.58
15.17
8.7
7.3
10.03
10.34
mmol/l
0.37
396
2630
1231
10115
1.37
15.11
4.8
4.1
138.27
100.54
e6/l
0.36
940
7245
640
4702
1.46
14.94
3.5
3.4
0.82
0.82
mmol/l
0.76
603
4442
497
3473
1.52
14.87
1.9
1.9
—
—
—
0
0
1055
8475
1.38
14.82
3.3
2.7
58.22
69.66
u/l
0.61
981
7866
982
7799
1.39
14.77
3.9
3.4
0.31
0.44
e6/l
2.09
782
5796
33
70
4.76
14.70
1.1
1.1
—
—
—
0
0
139
679
2.10
14.56
1.9
2.0
11.89
11.71
mg/l
0.08
131
622
1113
9062
1.37
14.22
4.2
3.5
66.51
48.33
mg/l
1.71
779
5927
206
1167
1.82
14.00
2.0
1.5
6.18
16.08
iu/ml
—
6
23
646
4828
1.43
13.61
1.8
1.8
1195.46
1166.30
nmol/l
0.33
503
3672
1151
9467
1.35
13.60
4.1
3.5
7.30
7.49
mmol/l
0.81
962
7997
147
754
2.00
13.50
1.4
1.6
1.22
1.18
g/l
0.94
142
720
143
732
2.00
13.21
1.4
1.6
0.24
0.24
g/l
0.38
138
700
77
305
2.57
13.12
1.4
1.6
—
—
—
0
0
365
2452
1.56
12.98
2.6
2.4
7.28
7.43
ug/l
0.03
316
2178
1122
9250
1.34
12.84
5.1
4.2
13.04
8.94
mg/mmol
1.66
752
5877
149
782
1.95
12.82
1.6
1.5
0.20
9.99
iu/ml
0.57
31
137
1467
12625
1.32
12.29
8.4
6.6
26.26
27.01
%
1.77
1400
11968
850
6757
1.36
12.22
2.9
2.5
—
—
—
0
0
129
655
2.01
12.21
1.8
1.9
3.68
12.99
iu/l
0.51
47
254
242
1497
1.67
12.07
4.8
3.9
47.86
47.41
%
0.10
237
1466
1438
12371
1.32
11.94
8.1
6.5
58.51
57.84
%
1.32
1387
11817
42
125
3.39
11.91
1.0
1.1
1575.43
1531.26
miu/ml
0.08
42
125
729
5683
1.38
11.78
1.8
1.8
17195775.07
28608078.01
pmol/l
0.27
599
4733
740
5825
1.36
11.15
1.8
1.8
1.34
1.36
mg/l
0.08
581
4560
906
7359
1.33
11.07
2.6
2.4
3.00
2.87
mg/l
0.89
816
6328
28
66
4.27
11.01
1.1
1.1
—
—
—
0
0
69
284
2.46
10.91
1.4
1.6
—
—
—
0
0
275
1803
1.58
10.83
9.3
9.7
24.31
24.27
mmol/l
0.06
269
1766
22
25
8.86
10.75
2.5
2.5
—
—
—
0
0
417
2993
1.46
10.70
5.0
3.7
1.96
1.85
mmol/l
0.23
367
2587
2485
23302
1.42
10.65
8.6
6.7
42.17
39.70
mmol/mol
22.00
2295
21742
2725
26031
1.61
10.62
30.5
23.0
82.70
79.97
umol/l
2.75
2698
25722
1828
16389
1.30
10.58
3.9
3.4
58.62
51.34
u/l
1.47
1703
15338
381
2703
1.47
10.37
8.2
7.7
1.32
1.37
mmol/l
0.55
372
2661
312
2144
1.51
9.93
4.8
4.1
106.13
93.06
ng/l
0.74
279
1853
46
162
2.87
9.91
3.0
2.6
226.10
229.39
e6/l
0.04
41
142
1360
11798
1.28
9.87
2.7
2.4
77.49
77.90
nmol/l
0.21
1225
10606
21
26
8.13
9.81
1.0
1.1
—
—
—
0
0
198
1232
1.65
9.67
2.0
1.9
3.37
2.13
ug/l
0.41
169
1087
213
1350
1.62
9.67
4.4
3.3
25.17
25.21
mmol/l
0.07
203
1298
615
4799
1.36
9.62
3.3
2.7
12.28
12.76
umol/l
0.92
571
4474
420
3076
1.43
9.62
4.8
3.7
5.87
5.83
kpa
0.41
405
2989
20
24
8.38
9.54
1.1
1.0
—
—
—
0
0
2692
25730
1.52
9.48
15.9
12.6
25.93
25.97
u/l
0.04
2611
24983
1330
11548
1.28
9.43
14.7
12.0
0.00
0.00
e9/l
2.88
1111
9384
245
1615
1.56
9.43
1.9
1.9
1.23
1.38
g/l
0.52
231
1490
21
28
7.55
9.40
1.2
1.2
—
—
—
0
0
1107
9402
1.28
9.35
3.5
3.6
2.35
2.35
mmol/l
0.10
988
8534
19
22
8.68
9.28
1.1
1.2
—
—
—
0
0
541
4164
1.37
9.21
3.4
2.7
21.89
22.64
%
0.59
502
3875
229
1497
1.57
9.14
1.6
1.5
—
—
—
0
0
96
488
2.00
9.14
1.3
1.2
431.43
525.13
titre
—
7
39
171
1041
1.68
9.09
1.9
2.2
278.31
486.58
ug/l
1.85
165
991
45
165
2.75
9.03
2.8
2.5
462.54
554.93
e6/l
0.58
37
134
358
2576
1.44
9.01
4.1
3.2
4.46
4.52
kpa
0.23
341
2500
575
4483
1.35
8.99
3.4
2.7
2.22
2.28
g/l
1.56
534
4140
2507
23713
1.38
8.73
6.0
5.4
6.25
6.00
mmol/l
10.51
2303
21660
1383
12144
1.26
8.65
2.3
2.2
96.67
94.59
pmol/l
0.83
725
6498
122
695
1.79
8.23
2.6
1.7
365.68
297.03
mu/l
0.86
113
632
2423
22855
1.34
8.14
4.9
4.4
1.33
1.29
mmol/l
1.75
2215
20909
68
319
2.16
8.05
1.8
1.6
25.18
29.62
ng/l
0.39
68
319
113
634
1.81
8.03
2.7
2.3
129.84
105.83
ug/min
0.29
67
390
154
947
1.66
7.91
1.2
1.2
0.98
1.16
u/ml
0.08
18
72
163
1021
1.63
7.80
2.7
3.6
39.24
69.06
mg/l
1.13
140
874
1348
11901
1.24
7.71
3.6
3.1
157.26
134.63
ug/l
1.46
1263
11066
19
31
6.16
7.53
1.2
1.2
—
—
—
0
0
229
1569
1.50
7.40
3.8
2.8
0.66
0.61
%
1.73
224
1560
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
157
988
1.62
7.38
2.5
2.9
0.34
0.34
iu/ml
0.05
73
537
110
629
1.78
7.37
2.5
2.9
32.81
36.13
umol/l
0.49
98
566
83
434
1.94
7.36
1.8
1.9
4.42
4.91
mmol/24h
0.69
73
377
193
1277
1.55
7.34
6.7
5.0
1.64
1.59
%
0.24
183
1199
161
1023
1.61
7.28
2.8
3.6
59.45
59.60
mg/l
0.01
137
874
607
4908
1.30
7.19
3.5
3.1
1.24
1.16
e6/l
0.20
364
2643
2743
26502
1.49
7.18
35.6
26.5
249.11
247.15
e9/l
0.81
2696
25953
2744
26518
1.49
7.13
35.8
26.7
133.36
134.43
g/l
3.15
2720
26224
2743
26508
1.49
7.11
35.5
26.4
91.06
91.38
fl
3.35
2717
26206
2743
26511
1.49
7.07
35.5
26.5
4.45
4.46
e12/l
0.42
2688
25869
2743
26511
1.49
7.07
36.2
27.0
39.90
40.28
%
1.19
2716
26193
441
3420
1.34
7.03
5.0
4.3
241.76
244.79
u/l
0.19
421
3244
2743
26515
1.49
7.02
35.6
26.5
7.04
6.80
e9/l
3.99
2687
25871
357
2680
1.38
7.01
2.6
2.7
65.28
69.65
e9/l
1.88
281
1968
609
4942
1.29
7.00
1.6
1.5
2.56
2.55
g/l
0.03
395
3022
25
76
3.31
6.96
4.1
2.2
1.56
1.15
ug/l
0.30
25
70
47
202
2.35
6.89
2.4
2.3
625.72
623.76
ml
0.01
32
131
941
8066
1.24
6.81
1.8
1.7
20.66
20.05
nmol/l
0.36
806
6819
128
782
1.67
6.79
2.0
1.8
—
—
—
0
0
228
1589
1.47
6.78
3.8
2.8
1.22
1.21
%
0.05
223
1578
2475
23561
1.31
6.72
21.8
17.2
77.79
78.45
ml/min/173m2
0.79
2346
21929
677
5599
1.27
6.65
1.3
1.3
1.14
1.56
u/ml
0.67
194
1473
2502
23870
1.32
6.56
5.8
5.2
1.42
1.44
mmol/l
2.23
2312
22073
2516
24027
1.32
6.51
6.0
5.3
4.37
4.54
mmol/l
13.51
2335
22370
36
142
2.55
6.36
1.2
1.5
5.07
8.15
u/l
1.59
26
126
2553
24453
1.33
6.29
6.8
6.0
2.49
2.63
mmol/l
13.47
2372
22675
235
1676
1.44
6.21
10.7
10.3
15.76
15.97
%
0.59
225
1613
174
1169
1.52
6.21
7.0
5.2
0.90
0.88
%
0.32
166
1096
656
5450
1.26
6.15
4.4
4.1
362.76
597.62
ng/l
0.50
539
4450
290
2150
1.39
6.14
3.0
2.8
63.69
64.88
ml/min/173m2
0.23
150
941
33
127
2.62
6.13
2.3
2.4
592.21
1193.58
u/ml
1.90
33
127
13
17
7.68
6.12
1.1
1.1
—
—
—
0
0
123
768
1.63
6.03
1.6
1.6
—
—
—
0
0
141
911
1.58
6.00
2.6
3.4
3.05
3.49
ratio
0.12
86
538
16
29
5.54
5.98
1.1
1.0
—
—
—
0
0
16
29
5.54
5.98
1.3
1.1
48.44
50.91
%
—
9
11
89
515
1.75
5.80
1.6
1.6
—
—
—
0
0
113
698
1.64
5.79
1.8
1.6
—
—
—
0
0
255
1870
1.40
5.77
4.5
3.2
127.53
128.71
g/l
0.35
243
1811
841
7229
1.23
5.74
4.3
3.5
0.83
0.06
estimate
0.46
305
2277
227
1642
1.41
5.56
3.5
3.8
1.78
1.90
mmol/l
0.20
167
1212
149
998
1.52
5.43
1.7
1.8
—
—
—
0
0
94
564
1.69
5.40
3.0
1.8
0.74
0.87
nmol/l
1.46
75
467
139
918
1.54
5.40
1.4
1.3
—
—
—
0
0
278
2096
1.36
5.32
1.8
1.6
—
—
—
0
0
189
1338
1.44
5.23
2.5
2.2
0.00
0.00
estimate
0.50
52
395
41
189
2.19
5.19
2.0
2.5
—
—
—
0
0
988
8710
1.20
5.10
3.6
3.3
34.42
36.66
u/l
0.37
934
8216
205
1483
1.41
5.04
3.5
3.4
4.38
4.48
pmol/l
0.77
187
1308
286
2197
1.33
4.85
5.4
4.0
1.22
1.22
mmol/l
0.03
253
1888
194
1402
1.41
4.81
1.7
1.8
1.63
1.53
g/l
0.72
168
1208
297
2297
1.33
4.81
3.8
2.4
0.47
0.49
e6/l
0.03
289
2203
114
744
1.55
4.71
1.5
1.5
—
—
—
0
0
101
642
1.59
4.68
2.0
1.4
8.89
9.24
u/l
0.10
80
511
55
296
1.87
4.61
1.7
1.8
—
1483.64
—
0
11
653
5579
1.22
4.60
3.1
3.1
2.45
2.46
mmol/l
0.28
579
5007
124
831
1.51
4.56
4.0
4.1
1.63
1.60
mg/l
0.12
110
750
812
7090
1.20
4.55
3.4
2.9
347.57
349.48
umol/l
0.20
727
6211
389
3143
1.27
4.53
3.1
2.9
7.51
8.32
umol/l
0.37
338
2803
99
633
1.58
4.49
1.1
1.1
5.31
3.53
—
8
67
91
573
1.61
4.40
6.8
5.5
1998.88
610.41
iu/ml
0.39
17
79
49
258
1.91
4.40
4.0
2.7
—
—
—
0
0
545
4592
1.23
4.38
1.3
1.3
29.27
34.28
iu/ml
0.35
141
1390
146
1020
1.45
4.38
1.9
1.7
5.56
7.08
iu/ml
0.56
40
236
165
2269
0.71
4.36
1.7
2.0
3.46
3.49
ratio
0.13
117
1776
1555
14382
1.17
4.35
2.9
2.8
—
—
—
0
0
355
2853
1.28
4.32
4.2
3.6
—
—
—
0
0
8
9
8.91
4.28
1.3
1.0
—
—
—
0
0
94
604
1.57
4.20
1.4
1.7
—
—
—
0
0
143
1005
1.44
4.17
2.7
2.7
—
—
—
0
0
251
1938
1.32
4.13
3.9
3.9
5.16
5.16
kpa
0.04
240
1861
43
223
1.94
4.06
2.0
1.5
351.13
318.30
mu/l
0.20
38
177
63
369
1.72
4.04
4.8
5.5
348.42
346.59
umol/l
0.03
52
327
146
1038
1.43
4.02
3.8
4.1
24.97
24.81
mmol/l
0.32
134
964
234
1803
1.32
3.92
5.3
3.8
24.20
24.17
mmol/l
0.04
229
1783
57
329
1.75
3.86
13.3
5.3
9.34
7.26
mmol/l
1.13
47
282
12
28
4.30
3.81
1.4
1.9
—
—
—
0
0
97
643
1.53
3.81
1.4
1.4
—
—
—
0
0
49
275
1.80
3.66
1.2
1.2
—
—
—
0
0
50
285
1.77
3.56
1.3
1.3
19.92
26.30
u/l
1.00
43
233
23
99
2.33
3.50
1.1
1.0
—
—
—
0
0
237
1861
1.30
3.49
1.9
1.7
—
—
—
0
0
120
1670
0.71
3.45
1.5
1.8
3.40
3.45
mmol/l
0.17
73
1178
83
546
1.54
3.41
1.4
1.4
—
—
—
0
0
81
530
1.54
3.41
1.2
1.2
52.77
47.92
u/ml
—
10
52
163
1225
1.35
3.28
2.1
2.4
3.86
3.72
g/l
0.26
149
1126
163
1226
1.35
3.26
2.1
2.4
7.52
7.42
g/l
0.30
149
1126
163
1226
1.35
3.26
2.1
2.4
4.19
4.19
g/l
0.02
149
1128
82
544
1.52
3.26
1.4
1.3
55.75
36.52
u/l
0.29
73
468
86
579
1.50
3.19
10.2
7.0
10.74
11.41
mmol/l
1.25
76
511
1042
9507
1.15
3.17
5.8
5.7
3.96
3.47
ug/l
0.12
930
8571
86
580
1.50
3.17
10.2
7.0
105.84
105.11
mmol/l
0.69
76
512
383
3226
1.22
3.08
5.3
5.0
32.91
32.60
%
0.21
282
2120
43
246
1.76
3.07
1.5
1.5
—
—
—
0
0
43
246
1.76
3.07
1.5
1.5
—
—
—
0
0
43
246
1.76
3.07
1.5
1.5
—
—
—
0
0
330
2746
1.23
2.99
2.4
2.3
0.20
0.21
g/l
0.13
301
2562
142
1064
1.35
2.94
1.9
2.4
10.01
10.32
g/l
0.34
125
955
12
37
3.25
2.93
8.4
13.1
4.89
5.71
mmol/l
0.85
12
37
8
17
4.72
2.92
1.0
1.1
—
—
—
0
0
497
4317
1.18
2.86
1.3
1.3
13.55
12.25
u/ml
0.11
189
1633
69
458
1.52
2.78
1.6
1.4
144.81
157.38
au/ml
0.32
21
138
59
378
1.57
2.78
1.5
1.6
—
—
—
0
0
18
78
2.32
2.74
1.1
1.2
—
—
—
0
0
24
118
2.04
2.71
1.3
2.7
64.33
108.07
umol/l
1.44
15
74
94
672
1.41
2.62
1.2
1.3
—
—
—
0
0
143
1094
1.32
2.61
2.0
2.0
—
—
—
0
0
67
449
1.50
2.60
1.3
1.4
—
—
—
0
0
8
20
4.01
2.56
1.0
1.1
—
—
—
0
0
148
1144
1.31
2.52
2.2
2.5
2.81
2.95
g/l
0.82
134
1045
97
704
1.39
2.49
1.2
1.2
8.43
7.56
u/ml
0.07
19
105
65
439
1.49
2.45
1.3
1.3
—
—
—
0
0
50
319
1.58
2.44
1.3
1.3
—
—
—
0
0
96
701
1.38
2.39
2.1
2.3
127.55
128.89
g/l
0.19
76
551
21
104
2.03
2.36
1.8
1.7
—
—
—
0
0
27
147
1.84
2.32
3.1
2.4
—
—
—
0
0
30
170
1.77
2.28
2.6
2.7
41.86
40.72
%
0.14
21
95
121
924
1.32
2.28
1.9
1.4
26.55
27.74
iu/l
0.13
99
786
50
325
1.55
2.27
1.5
1.3
274.95
277.13
mosm/kgh2o
0.28
41
237
33
193
1.72
2.26
1.2
1.2
—
—
—
0
0
95
702
1.37
2.23
1.2
1.2
1.28
3.48
u/ml
2.38
13
63
37
225
1.65
2.21
1.6
1.6
—
—
—
0
0
20
102
1.97
2.10
1.8
1.7
—
—
—
0
0
20
102
1.97
2.10
1.8
1.7
—
—
—
0
0
20
369
0.54
2.08
1.4
1.5
66.78
62.17
ug/l
0.11
15
311
9
31
2.91
2.07
1.0
1.1
—
—
—
0
0
35
215
1.64
2.03
1.3
1.5
13.43
13.49
u/l
0.02
35
207
826
7606
1.12
2.02
4.8
4.7
22.40
21.83
%
0.47
414
3854
101
767
1.33
2.01
2.5
2.7
193.42
193.64
%
0.01
96
731
1121
10499
1.11
2.01
2.1
1.9
1.34
1.35
mmol/l
0.20
932
8793
40
255
1.58
2.01
1.2
1.2
56.69
63.62
u/l
0.44
35
224
25
140
1.79
2.00
1.2
1.2
—
—
—
0
0
50
337
1.49
1.96
2.5
2.3
17.93
21.10
mg/l
0.18
17
121
7
21
3.34
1.96
1.4
1.2
—
—
—
0
0
79
580
1.37
1.96
1.2
1.2
1.19
4.70
u/ml
—
7
38
134
1062
1.27
1.95
2.3
2.5
1.77
1.16
g/l
0.57
116
913
503
4506
1.14
1.93
3.8
3.3
3.04
2.20
e6/l
0.83
253
2237
25
142
1.77
1.92
1.2
1.4
—
—
—
0
0
20
106
1.89
1.90
1.4
1.2
—
—
—
0
0
78
576
1.36
1.88
2.3
2.2
1525.38
5592.94
u/l
1.94
29
241
37
236
1.58
1.87
1.6
1.8
7.37
4.60
mg/l
0.65
37
229
34
213
1.60
1.85
1.0
1.0
—
—
—
0
0
49
334
1.47
1.84
1.3
1.3
321.18
316.35
pmol/l
0.03
38
286
187
1554
1.22
1.81
1.3
1.2
158.04
146.94
u/ml
0.13
73
565
18
94
1.92
1.80
1.1
1.1
—
—
—
0
0
8
29
2.76
1.79
1.0
1.0
—
—
—
0
0
425
3794
1.14
1.73
1.5
1.5
—
—
—
0
0
18
96
1.88
1.70
2.4
2.6
0.63
0.62
mmol/l
0.23
18
96
29
179
1.63
1.69
1.3
1.2
—
—
—
0
0
16
82
1.96
1.69
1.4
1.2
—
—
—
0
0
46
316
1.46
1.69
1.5
1.3
0.16
0.25
nmol/l
0.82
36
256
64
468
1.38
1.67
1.3
1.3
240.76
266.24
u/ml
0.35
45
274
110
872
1.27
1.65
2.3
2.4
0.00
0.00
g/l
-0.00
94
762
54
385
1.41
1.64
1.2
1.2
5.96
3.03
u/ml
0.39
23
137
48
335
1.44
1.63
1.2
1.1
—
—
—
0
0
29
181
1.61
1.63
1.3
1.2
—
—
—
0
0
26
158
1.65
1.62
1.3
1.4
1.00
1.20
nmol/l
0.42
15
108
22
128
1.72
1.60
5.7
3.3
0.75
1.06
%
0.59
22
128
7
26
2.70
1.58
1.1
1.6
—
—
—
0
0
2080
20215
1.10
1.55
28.1
21.5
13.86
13.72
%
4.26
2058
19934
55
399
1.39
1.53
1.1
1.1
33.76
21.60
au/ml
0.39
13
84
29
185
1.57
1.51
2.4
1.8
—
—
—
0
0
92
723
1.28
1.50
1.6
1.3
—
—
—
0
0
51
368
1.39
1.47
1.6
1.6
—
—
—
0
0
15
80
1.88
1.44
1.2
1.2
108.40
107.99
%
0.02
15
72
11
52
2.12
1.44
3.4
2.1
—
—
—
0
0
6
22
2.73
1.43
1.0
1.5
—
—
—
0
0
21
340
0.61
1.43
1.3
1.5
1.43
1.14
ratio
0.54
11
218
21
340
0.61
1.43
1.3
1.5
1.16
1.21
ratio
0.10
11
218
21
340
0.61
1.43
1.3
1.5
0.83
0.97
ratio
1.03
11
218
101
809
1.26
1.42
2.3
2.4
0.00
0.00
g/l
-0.00
94
761
21
338
0.62
1.40
1.3
1.4
—
—
—
0
0
776
7251
1.10
1.39
3.6
3.1
0.00
0.04
1.28
17
188
11
53
2.08
1.38
3.4
2.1
—
—
—
0
0
165
1397
1.19
1.37
4.4
3.6
1.02
1.02
ratio
0.59
152
1272
58
437
1.33
1.31
1.2
1.1
2643.68
83.36
iu/ml
0.50
13
87
75
589
1.28
1.27
1.5
1.5
—
—
—
0
0
101
822
1.24
1.27
1.5
1.4
260.10
274.70
ug/g
0.38
68
485
30
203
1.48
1.24
1.0
1.0
718.76
694.63
ng/l
0.08
17
129
30
204
1.48
1.22
1.0
1.0
29.51
44.56
ng/l
1.67
16
130
86
691
1.25
1.22
1.3
1.1
—
—
—
0
0
11
56
1.97
1.22
1.2
1.5
—
—
—
0
0
50
374
1.34
1.20
1.2
1.2
5.33
5.39
u/ml
0.01
18
176
22
140
1.58
1.20
1.8
1.6
—
—
—
0
0
22
140
1.58
1.20
1.8
1.6
—
—
—
0
0
22
140
1.58
1.20
1.8
1.6
—
—
—
0
0
22
140
1.58
1.20
1.8
1.6
—
—
—
0
0
2065
20158
1.08
1.18
30.7
22.6
331.59
332.07
g/l
1.58
2051
20038
108
896
1.21
1.15
2.3
2.4
0.00
0.02
g/l
2.04
98
803
8
40
2.00
1.12
1.3
3.7
48.63
42.08
umol/l
—
8
32
5
21
2.38
1.09
1.0
1.3
5.70
6.18
mmol/l
—
5
21
142
1216
1.18
1.09
1.1
1.1
—
1.45
—
0
13
53
683
0.77
1.09
1.1
1.1
0.53
0.65
ratio
—
7
93
85
694
1.23
1.07
1.3
1.1
—
—
—
0
0
290
2614
1.12
1.07
3.0
2.5
45.11
58.24
u/l
0.29
235
2196
342
3112
1.11
1.07
2.4
2.4
175.48
144.57
ug/g
0.66
260
2501
71
569
1.25
1.06
1.2
1.3
—
—
—
0
0
71
569
1.25
1.06
1.2
1.3
—
—
—
0
0
23
153
1.51
1.06
1.3
1.5
10.75
6.14
u/l
0.58
16
124
13
217
0.60
1.05
1.4
1.5
—
—
—
0
0
92
760
1.22
1.05
4.1
3.5
2.33
1.90
index
0.21
49
390
68
544
1.26
1.04
1.5
1.4
—
—
—
0
0
5
22
2.27
1.03
12.2
5.0
—
—
—
0
0
5
22
2.27
1.03
1.0
1.0
—
—
—
0
0
29
204
1.43
1.03
1.0
1.0
242.94
320.24
ng/l
0.94
16
133
14
83
1.69
1.01
1.1
1.0
—
—
—
0
0
22
147
1.50
1.00
1.3
1.2
69.53
20.35
u/l
1.20
17
120
7
35
2.00
1.00
1.0
1.1
—
—
—
0
0
7
36
1.95
0.97
1.0
1.1
—
—
—
0
0
51
646
0.79
0.94
1.4
1.6
1050.05
994.56
mu/l
0.17
42
538
7
37
1.89
0.94
1.0
1.2
116.00
95.95
%
—
7
37
40
303
1.32
0.93
1.4
1.6
57.25
62.29
%
0.27
20
187
10
55
1.82
0.92
1.3
1.2
—
—
—
0
0
6
28
2.15
0.91
1.0
1.5
—
—
—
0
0
30
219
1.37
0.89
1.5
1.2
—
—
—
0
0
224
2019
1.12
0.87
1.4
1.5
—
—
—
0
0
22
153
1.44
0.85
1.3
1.2
157.76
90.24
u/l
0.96
17
127
16
104
1.54
0.84
1.2
1.3
145.50
173.28
mmol/24h
0.64
16
104
15
96
1.57
0.84
1.1
1.3
—
—
—
0
0
35
265
1.32
0.84
4.5
3.6
12.29
11.07
index
0.49
21
152
126
1098
1.15
0.83
1.3
1.3
—
—
—
0
0
137
1205
1.14
0.80
1.1
1.1
—
—
—
0
0
43
339
1.27
0.79
1.1
1.4
—
—
—
0
0
248
2266
1.10
0.77
2.6
2.4
12.13
12.94
nmol/l
0.79
222
2031
10
59
1.70
0.75
18.6
6.9
7.49
5.38
kpa
—
10
59
21
289
0.72
0.73
1.6
1.7
—
—
—
0
0
62
743
0.83
0.73
1.1
1.1
1.59
1.53
g/l
1.12
62
743
11
172
0.64
0.73
2.8
1.5
110.91
87.58
umol/l
0.52
11
172
102
885
1.16
0.73
2.3
1.9
—
—
—
0
0
9
55
1.64
0.73
1.0
1.2
—
—
—
0
0
9
56
1.61
0.72
1.8
1.6
—
—
—
0
0
11
68
1.62
0.71
2.5
2.6
3.64
506.88
ug/l
0.63
11
68
7
40
1.75
0.71
5.3
7.6
11.69
10.52
%
—
7
40
16
109
1.47
0.70
1.2
1.5
—
1679007.00
—
0
7
20
143
1.40
0.70
1.2
1.2
135.25
135.11
nmol/l
0.00
20
143
16
110
1.46
0.68
1.5
2.4
233.75
798.33
e6/l
—
8
84
7
118
0.59
0.67
1.1
1.3
—
—
—
0
0
30
232
1.30
0.66
1.2
1.5
34.15
29.20
%
0.23
15
141
13
86
1.51
0.66
2.2
2.8
4.67
4.97
kpa
0.55
13
86
12
79
1.52
0.62
1.4
1.6
68.42
155.68
nmol/24h
0.55
12
79
19
138
1.38
0.62
1.7
2.2
209.20
133.63
ug/min
—
5
35
20
147
1.36
0.61
2.6
3.6
—
—
—
0
0
27
209
1.29
0.60
1.3
1.2
—
314.00
—
0
5
44
362
1.22
0.60
1.0
1.1
—
—
—
0
0
34
421
0.81
0.59
1.5
1.5
—
—
—
0
0
6
35
1.72
0.57
1.0
1.1
—
—
—
0
0
23
298
0.77
0.57
1.0
1.1
2.04
2.37
eliau/ml
—
10
120
95
839
1.14
0.57
1.7
1.6
—
—
—
0
0
41
337
1.22
0.57
1.1
1.4
—
—
—
0
0
316
2966
1.07
0.56
3.9
4.3
55.61
20.69
ug/l
0.31
267
2453
78
681
1.15
0.56
1.2
1.2
—
—
—
0
0
17
124
1.37
0.55
3.4
1.7
40.95
40.06
g/l
0.28
17
124
119
1070
1.12
0.55
3.1
3.4
94.01
4089.65
u/ml
0.93
104
928
12
82
1.47
0.54
1.2
1.2
88.71
88.53
%
—
7
45
88
780
1.13
0.52
1.2
1.3
—
—
—
0
0
29
233
1.25
0.51
1.2
1.1
—
56.00
—
0
9
6
41
1.46
0.50
2.3
1.7
0.43
0.48
e9/l
—
6
41
38
316
1.21
0.49
1.7
1.5
0.20
0.31
nmol/l
1.54
29
239
19
145
1.31
0.48
2.4
1.6
—
—
—
0
0
19
145
1.31
0.48
2.4
1.6
—
—
—
0
0
22
172
1.28
0.48
1.5
1.5
—
—
—
0
0
72
815
0.88
0.47
1.7
1.7
3.17
4.76
mg/l
0.90
54
608
7
49
1.43
0.46
1.1
1.1
—
—
—
0
0
26
320
0.81
0.45
1.4
1.6
—
—
—
0
0
26
210
1.24
0.45
1.2
1.2
—
—
—
0
0
38
320
1.19
0.44
1.1
1.4
—
—
—
0
0
12
86
1.40
0.44
2.3
2.8
9.56
10.19
kpa
0.44
12
86
25
202
1.24
0.43
1.1
1.5
1.31
1.23
promille
0.08
16
157
336
3198
1.06
0.42
1.5
1.5
—
—
—
0
0
10
70
1.43
0.41
2.0
1.4
8.90
8.88
ug/l
—
10
70
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
8
59
1.36
0.41
2.6
3.3
—
81.74
—
0
12
42
361
1.17
0.40
1.2
1.1
—
11.27
—
0
15
16
123
1.30
0.40
1.1
1.1
—
—
—
0
0
113
1037
1.09
0.39
1.7
1.7
0.26
0.34
mg/l
0.81
50
499
68
608
1.12
0.38
1.1
1.1
1.40
5.60
eliau/ml
—
5
65
16
124
1.29
0.38
2.9
7.4
—
56.24
—
0
33
21
169
1.24
0.38
1.9
1.9
102.57
115.90
ng/l
0.21
21
169
5
76
0.66
0.35
1.4
1.4
—
—
—
0
0
6
43
1.40
0.35
1.2
1.3
—
—
—
0
0
28
236
1.19
0.35
1.9
1.5
34.25
23.62
u/ml
—
8
39
10
73
1.37
0.34
3.5
4.1
4.74
8.42
mg/l
—
10
62
22
181
1.22
0.34
1.0
1.1
—
—
—
0
0
11
82
1.34
0.34
1.3
1.5
85.17
89.33
%
—
6
46
32
274
1.17
0.34
1.1
1.2
100.94
94.96
%
0.94
32
259
37
321
1.15
0.33
1.1
1.4
—
—
—
0
0
27
228
1.19
0.33
1.0
1.1
—
—
—
0
0
69
625
1.11
0.33
1.2
1.3
222.05
229.63
miu/ml
0.05
22
264
12
92
1.31
0.31
1.3
1.3
1.60
513.00
ug/l
—
6
39
37
323
1.15
0.31
1.1
1.4
—
—
—
0
0
63
570
1.11
0.31
6.8
3.6
27.08
27.78
mg/l
0.06
40
391
28
239
1.17
0.31
1.4
1.5
—
—
—
0
0
7
52
1.35
0.31
1.9
1.4
—
—
—
0
0
38
334
1.14
0.30
1.1
1.4
—
—
—
0
0
13
102
1.28
0.30
1.1
1.2
8.15
10.75
mm/h
0.97
13
102
30
261
1.15
0.27
1.4
1.3
172616.45
104513.51
e6/l
0.18
20
171
20
168
1.19
0.27
1.5
1.5
—
—
—
0
0
114
1070
1.07
0.26
2.4
2.0
—
—
—
0
0
20
169
1.18
0.25
1.7
2.1
9.20
8.32
mmol/l
0.27
20
169
23
199
1.16
0.23
1.0
1.1
—
—
—
0
0
67
723
0.92
0.23
1.6
1.6
9733.30
14441.56
e6/l
0.56
47
494
22
190
1.16
0.23
1.0
1.1
—
—
—
0
0
22
190
1.16
0.23
1.0
1.1
—
—
—
0
0
24
209
1.15
0.22
2.5
2.7
27.65
29.93
mg/l
0.09
17
153
22
191
1.15
0.22
1.5
1.5
—
—
—
0
0
194
2018
0.96
0.21
2.1
2.1
—
—
—
0
0
5
42
1.19
0.21
1.0
1.6
16.53
33.16
pmol/l
—
5
36
53
488
1.09
0.21
1.3
1.5
80.58
219.80
pmol/l
2.97
53
481
0
12
0.00
0.21
0.0
2.8
—
1.48
—
0
12
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
2.83
—
0
12
11
89
1.24
0.21
1.5
1.4
—
—
—
0
0
575
5636
1.03
0.20
3.2
3.4
0.73
0.77
ug/l
0.42
402
3805
42
384
1.10
0.20
1.4
1.6
—
—
—
0
0
68
636
1.07
0.19
3.6
3.3
0.71
0.82
nmol/l
2.45
52
514
35
384
0.91
0.18
1.1
1.1
2.04
4.82
u/ml
2.21
15
208
7
61
1.15
0.17
1.0
1.1
—
—
—
0
0
165
1592
1.04
0.17
1.4
1.3
136.34
208.83
u/ml
1.72
154
1479
25
225
1.11
0.16
2.3
2.1
21.87
11.33
umol/l
0.26
16
157
68
642
1.06
0.16
1.5
1.5
—
—
—
0
0
240
2336
1.03
0.15
3.5
3.0
260.83
213.85
ng/l
0.58
220
2136
64
604
1.06
0.15
2.7
3.4
104.27
750.37
u/ml
0.89
58
562
283
2762
1.03
0.15
1.7
1.8
1.53
1.53
%
0.03
238
2414
23
207
1.11
0.15
1.1
1.2
110.43
105.71
pmol/l
0.13
23
207
29
265
1.10
0.14
1.0
1.0
0.18
0.32
u/ml
—
10
92
10
118
0.85
0.14
1.1
1.4
—
—
—
0
0
10
118
0.85
0.14
1.1
1.4
—
—
—
0
0
8
100
0.80
0.13
1.0
1.9
—
—
—
0
0
22
242
0.91
0.13
1.3
1.3
—
—
—
0
0
24
219
1.10
0.12
6.2
5.2
247.31
32.76
u/ml
—
8
71
40
375
1.07
0.12
1.2
1.1
—
—
—
0
0
35
373
0.94
0.11
1.1
1.1
0.23
1.48
u/ml
2.27
13
170
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
13
115
1.13
0.10
1.3
2.0
156.00
164.73
%
0.11
13
110
43
454
0.95
0.10
1.1
1.1
0.19
1.89
u/ml
5.02
20
260
32
341
0.94
0.10
1.5
1.4
48722.46
91096.32
e6/l
0.64
24
198
18
197
0.91
0.10
1.3
1.3
0.46
1.55
u/ml
—
10
110
92
891
1.03
0.09
1.6
1.6
41.03
15.67
u/ml
0.74
17
191
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
6
58
1.03
0.08
1.0
1.4
1.23
1.17
mmol/l
—
6
58
37
389
0.95
0.08
1.4
1.4
16297.53
3942.22
e6/l
0.40
32
276
30
284
1.06
0.07
1.0
1.1
0.40
4.90
u/ml
3.59
13
126
12
108
1.11
0.07
1.3
1.1
—
—
—
0
0
13
142
0.92
0.06
2.2
1.5
13.29
7.36
ug/l
0.45
13
126
77
750
1.03
0.06
1.4
1.4
—
—
—
0
0
25
237
1.06
0.05
1.3
1.6
56.61
54.98
ug/l
0.07
25
237
32
306
1.05
0.05
1.0
1.1
0.76
3.01
u/ml
1.90
16
156
21
222
0.95
0.05
1.1
2.1
2.31
1.66
u/field
0.29
13
121
17
159
1.07
0.05
1.3
1.4
164.52
214.00
pmol/l
0.37
17
159
37
360
1.03
0.03
1.1
1.1
1.02
1.47
u/ml
0.19
16
191
12
112
1.07
0.03
1.2
1.3
6.00
6.10
mmol/l
0.13
12
107
11
118
0.93
0.02
1.2
1.1
—
—
—
0
0
17
178
0.95
0.02
1.2
1.3
—
—
—
0
0
120
1190
1.01
0.01
3.1
3.7
85.73
80.93
u/ml
0.03
113
1152
30
307
0.98
0.01
3.4
3.8
—
—
—
0
0
186
1852
1.00
0.01
2.0
2.0
—
—
—
0
0
15
155
0.97
0.00
1.0
1.1
22.63
18.01
u/ml
—
6
59
12
121
0.99
0.00
11.7
13.0
0.61
0.62
mmol/l
0.04
12
112
18
181
0.99
0.00
1.2
1.3
—
—
—
0
0
19
186
1.02
0.00
1.1
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
13
130
1.00
-0.00
1.0
1.1
—
—
—
0
0
70
700
1.00
-0.00
1.5
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
1.30
—
0
8
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
71
0.99
-0.00
1.6
2.3
6.66
8.85
mg/l
—
7
57
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
-0.00
1.0
1.1
97.16
50.65
u/ml
—
5
51
Mortality – FinRegistry
↥Association
Association between endpoint H7_PARASTRAB and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_PARASTRAB | 1.349 [1.22, 1.49] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.034 |
During the follow-up period (1.1.1998 — 31.12.2019), 1840 out of 7311 females with H7_PARASTRAB died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_PARASTRAB | 1.428 [1.29, 1.58] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.01 |
During the follow-up period (1.1.1998 — 31.12.2019), 2050 out of 7503 males with H7_PARASTRAB died.
Mortality risk
Mortality risk for people of age
years, who have H7_PARASTRAB.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.105% | 0.282% |
| 5 | 0.75% | 1.616% |
| 10 | 1.723% | 4.105% |
| 15 | 3.265% | 8.143% |
| 20 | 5.54% | 13.415% |
Relationships between endpoints
↥Index endpoint: H7_PARASTRAB – Paralytic strabismus
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data